XNA-3

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameXNA-3
Drug Alias NameXNA-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 5 alpha reductase inhibitors
TargetsSteroid 5 alpha reductase
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXenna Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXenna Corp
Active IndicationsN/A
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A